Claims: STAT+: Novartis gets multiple sclerosis win with BTK inhibitor

These are attributed source records, not independent verification of each assertion.

Complete claim record (JSON) · Original source

1. title: STAT+: Novartis gets multiple sclerosis win with BTK inhibitor (alleges; supported) Source
2. url: https://www.statnews.com/2026/09/01/biotech-news-novartis-gets-multiple-sclerosis-win-with-btk-inhibitor/?utm_campaign=rss (alleges; supported) Source
3. summary: Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I know this week probably feels extra long as we approach Labor Day weekend, but we will get through it together. The need-to-know this morning Alumis said its experimental treatment for lupus failed to achieve the efficacy goals of a mid-stage clinical trial. Trump strikes more drug pricing deals with biotechs President Trump yesterday announced that his admi… (alleges; supported) Source
4. published: Tue, 01 Sep 2026 13:34:13 +0000 (alleges; supported) Source